Drug:
Reaction: ILLNESS
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555368 |
US |
2 | |
Nephrolithiasis, Illness, |
||||
INCLISIRAN, |
||||
| 2 | 26555469 |
US |
2 | |
Abdominal pain upper, Chest pain, Illness, Disease recurrence, Product use complaint, |
||||
RABEPRAZOLE, |
||||
| 3 | 26555528 |
US |
2 | |
Neuropathy peripheral, Illness, Muscular weakness, |
||||
OLAPARIB, |
||||
| 4 | 26555649 |
|||
Psoriatic arthropathy, Illness, Haemorrhagic diathesis, Staphylococcal infection, |
||||
BIMEKIZUMAB, CYCLOBENZAPRINE, SERTRALINE, GABAPENTIN, FOLIC ACID, MAGNESIUM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 5 | 26555662 |
US |
2 | |
Malaise, Illness, Vomiting, Abdominal discomfort, |
||||
RAVULIZUMAB, |
||||
| 6 | 26555963 |
US |
||
Anxiety, Illness, |
||||
TIRZEPATIDE, |
||||
| 7 | 26556230 |
GB |
||
Illness, Gastritis, |
||||
| 8 | 26556513 |
US |
60 | 2 |
Therapy interrupted, Metapneumovirus infection, Oxygen saturation decreased, Speech disorder, Illness, |
||||
| 9 | 26556567 |
IL |
13 | 2 |
Immune thrombocytopenia, Obesity, Immune system disorder, Pneumonia, Pneumonia, Maternal exposure before pregnancy, Unwanted pregnancy, Illness, Hepatic function abnormal, Cholecystitis, Poor dental condition, Hypersensitivity, Abdominal pain lower, Vaccination site pain, Dizziness, Heavy menstrual bleeding, Oropharyngeal pain, Urinary tract infection, Pancreatitis, Anxiety, Depression, Intermenstrual bleeding, Hormone level abnormal, Iron deficiency anaemia, Uterine cervical laceration, Suicidal ideation, Productive cough, Lumbar spinal stenosis, Blood potassium abnormal, Blood glucose abnormal, Cholelithiasis, Presyncope, |
||||
| 10 | 26556575 |
US |
42 | 2 |
Illness, Influenza, Taste disorder, Poor quality sleep, Vomiting, Eructation, Diarrhoea, Nausea, |
||||
TIRZEPATIDE, |
||||
| 11 | 26556704 |
US |
42 | 2 |
Illness, Vomiting, Abdominal distension, Abdominal discomfort, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 12 | 26556877 |
IL |
||
Illness, |
||||
NIRSEVIMAB, |
||||
| 13 | 26556878 |
IL |
3 | |
Illness, |
||||
NIRSEVIMAB, |
||||
| 14 | 26556919 |
US |
||
Gastric cancer recurrent, Illness, Weight decreased, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 15 | 26557220 |
US |
2 | |
Contraindication to medical treatment, Intentional overdose, Illness, Neuralgia, Pain in extremity, Arthralgia, Muscle spasms, Dry skin, Throat irritation, Neck pain, Hypersensitivity, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 16 | 26557320 |
US |
8 | 1 |
Illness, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 17 | 26557327 |
GB |
25 | 2 |
Illness, Vomiting, Abdominal pain upper, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, QUETIAPINE, |
||||
| 18 | 26557878 |
US |
1 | |
Inflammation, Myasthenia gravis, Illness, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 19 | 26557942 |
US |
59 | 2 |
Pain, Illness, Fatigue, Dyspepsia, Vomiting, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 20 | 26558040 |
US |
1 | |
Illness, |
||||
DUPILUMAB, AMOXICILLIN, CETIRIZINE HCL, CETIRIZINE, DESONIDE, MUPIROCIN, MUPIROCIN CALCIUM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 21 | 26558065 |
US |
54 | 2 |
Illness, |
||||
SARILUMAB, |
||||
| 22 | 26558385 |
63 | ||
Skin infection, Ankle operation, Osteomyelitis, Illness, |
||||
CERTOLIZUMAB PEGOL, ALBUTEROL SULFATE, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, BISOPROLOL FUMARATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DICYCLOMINE HYDROCHLORIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, DAPAGLIFLOZIN, GABAPENTIN, CALCIUM CARBONATE, SIMETHICONE, SIMETHICONE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, NIFEDIPINE, NITROGLYCERIN, SEMAGLUTIDE, ORAL SEMAGLUTIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PRIMIDONE, QUETIAPINE FUMARATE, QUETIAPINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VITAMIN C, ERGOCALCIFEROL, |
||||
| 23 | 26559187 |
80 | 2 | |
Illness, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 24 | 26559293 |
US |
4 | 1 |
Illness, |
||||
ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 25 | 26559347 |
US |
1 | |
Illness, |
||||
| 26 | 26559350 |
US |
2 | |
Illness, Product dose omission issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 27 | 26559373 |
GB |
2 | |
Lower respiratory tract infection, Illness, Tender joint count increased, General physical health deterioration, |
||||
METHOTREXATE SODIUM, SECUKINUMAB, |
||||
| 28 | 26559481 |
US |
65 | 1 |
Illness, |
||||
ABATACEPT, |
||||
| 29 | 26559613 |
US |
71 | 2 |
Mobility decreased, Asthenia, Illness, Gastrointestinal disorder, Headache, Nausea, |
||||
SEMAGLUTIDE, |
||||
| 30 | 26559660 |
|||
Sepsis, Illness, |
||||
CERTOLIZUMAB PEGOL, HYDROMORPHONE HYDROCHLORIDE, GABAPENTIN, DEXAMETHASONE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, TIMOLOL MALEATE, ROSUVASTATIN, MIRTAZAPINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, PANTOPRAZOLE, |
||||
| 31 | 26559979 |
US |
64 | |
Gingivitis, Illness, Therapy interrupted, |
||||
ANAKINRA, |
||||
| 32 | 26560014 |
US |
49 | 1 |
Hypotension, Renal pain, Illness, Laboratory test abnormal, |
||||
SPARSENTAN, |
||||
| 33 | 26560212 |
US |
2 | |
Illness, |
||||
DUPILUMAB, |
||||
| 34 | 26560240 |
US |
3 | 2 |
Influenza, Illness, Poor venous access, |
||||
LARONIDASE, LARONIDASE, |
||||
| 35 | 26560308 |
US |
57 | 2 |
Illness, |
||||
DUPILUMAB, |
||||
| 36 | 26560456 |
US |
46 | |
Hand-foot-and-mouth disease, Enterovirus infection, Acute flaccid myelitis, Illness, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
| 37 | 26560536 |
CA |
1 | |
Illness, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, LENALIDOMIDE, |
||||
| 38 | 26560746 |
US |
2 | |
Organ failure, Unevaluable event, Emotional distress, Drug ineffective, Gastrointestinal injury, Liver injury, Illness, Off label use, |
||||
PANCRELIPASE, |
||||
| 39 | 26560767 |
|||
Skin discolouration, Carpal tunnel syndrome, Weight increased, Illness, Stress, Sleep apnoea syndrome, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, ERGOCALCIFEROL, |
||||
| 40 | 26560831 |
US |
1 | |
Illness, |
||||
SPARSENTAN, |
||||
| 41 | 26560857 |
US |
1 | |
Mycobacterium avium complex infection, Illness, Emphysema, Bronchitis, |
||||
| 42 | 26560875 |
US |
2 | |
Protein urine present, Illness, |
||||
SPARSENTAN, |
||||
| 43 | 26561020 |
US |
40 | 2 |
Hypotension, Illness, Nausea, Vomiting, Asthenia, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 44 | 26561073 |
US |
2 | |
Fatigue, Illness, Chromaturia, Weight increased, Product administration error, |
||||
SPARSENTAN, |
||||
| 45 | 26561318 |
61 | 2 | |
Illness, |
||||
TIRZEPATIDE, |
||||
| 46 | 26561561 |
US |
63 | 2 |
Spinal operation, Psoriasis, Fatigue, Pain, Fatigue, Fatigue, Dental care, Illness, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 47 | 26550063 |
US |
14 | 2 |
Illness, |
||||
DUPILUMAB, |
||||
| 48 | 26550080 |
US |
2 | |
Illness, Malaise, |
||||
DUPILUMAB, |
||||
| 49 | 26550148 |
US |
70 | 1 |
Illness, |
||||
INSULIN LISPRO, INSULIN GLARGINE, PREDNISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 50 | 26550338 |
US |
1 | |
Lung neoplasm malignant, Illness, |
||||
ETANERCEPT, |
||||
| 51 | 26550405 |
40 | ||
Psoriasis, Illness, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, FOLLITROPIN, |
||||
| 52 | 26550635 |
65 | ||
Fall, Femur fracture, Prosthesis implantation, Weight decreased, Illness, |
||||
CERTOLIZUMAB PEGOL, CLONAZEPAM, RISPERIDONE, MIRTAZAPINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 53 | 26550739 |
US |
1 | |
Gastrooesophageal reflux disease, Illness, Vomiting, Nausea, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 54 | 26551024 |
US |
65 | 2 |
Illness, Nausea, Drug ineffective, Blood glucose abnormal, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 55 | 26551029 |
US |
37 | 2 |
Illness, Vomiting, Fatigue, Dizziness, Abdominal pain upper, |
||||
TIRZEPATIDE, |
||||
| 56 | 26551096 |
US |
76 | 2 |
Pulmonary hypertension, Illness, Cough, Cardiac disorder, |
||||
DUPILUMAB, DUPILUMAB, ROSUVASTATIN CALCIUM, MAGNESIUM OXIDE, ERGOCALCIFEROL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 57 | 26551113 |
US |
60 | 2 |
Illness, |
||||
LENALIDOMIDE, |
||||
| 58 | 26551238 |
US |
23 | 2 |
Illness, Product use in unapproved indication, |
||||
CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, |
||||
| 59 | 26551284 |
US |
2 | |
Respiratory syncytial virus infection, Illness, |
||||
DUPILUMAB, |
||||
| 60 | 26551473 |
US |
1 | |
Memory impairment, Illness, Migraine, Product dose omission issue, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 61 | 26551564 |
US |
2 | |
Ankylosing spondylitis, Illness, Decreased immune responsiveness, COVID-19, |
||||
ETANERCEPT, |
||||
| 62 | 26551689 |
US |
2 | |
Illness, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 63 | 26551765 |
US |
2 | |
Illness, |
||||
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 64 | 26551984 |
US |
57 | 1 |
Haematochezia, Anger, Feeling hot, Pain, Inflammation, Back pain, Pruritus, Nausea, Gastrointestinal sounds abnormal, Defaecation urgency, Dyschezia, Illness, Off label use, Product dose omission issue, Musculoskeletal stiffness, Urticaria, Abdominal pain, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 65 | 26551993 |
US |
2 | |
Illness, Pyrexia, |
||||
OFATUMUMAB, |
||||
| 66 | 26552072 |
CO |
61 | 2 |
Deafness, Illness, Malaise, |
||||
PANITUMUMAB, |
||||
| 67 | 26552154 |
73 | ||
Death, Illness, Infection, Inappropriate schedule of product administration, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 68 | 26552943 |
US |
59 | 2 |
Illness, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 69 | 26552947 |
65 | ||
Illness, Nausea, Diarrhoea, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, FUROSEMIDE, ERGOCALCIFEROL, |
||||
| 70 | 26553469 |
US |
2 | |
Illness, |
||||
SEMAGLUTIDE, |
||||
| 71 | 26553659 |
61 | 2 | |
Illness, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 72 | 26553731 |
US |
59 | 2 |
Illness, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 73 | 26553913 |
US |
2 | |
Disability, Illness, Product dose omission issue, |
||||
BELIMUMAB, |
||||
| 74 | 26553961 |
US |
2 | |
Illness, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, FENTANYL, LORAZEPAM, FAMOTIDINE, SENNA LEAF, RIZATRIPTAN, LOSARTAN POTASSIUM, LOSARTAN, TIZANIDINE HYDROCHLORIDE, |
||||
| 75 | 26554178 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
| 76 | 26554317 |
|||
Rheumatoid arthritis, Illness, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 77 | 26554349 |
US |
59 | 2 |
Illness, |
||||
TIRZEPATIDE, |
||||
| 78 | 26554350 |
US |
50 | 2 |
Illness, |
||||
DULAGLUTIDE, |
||||
| 79 | 26554388 |
CA |
1 | |
Pneumonia, Sinusitis, Dyspnoea, Malaise, Illness, |
||||
ALBUTEROL SULFATE, MOMETASONE FUROATE, MONTELUKAST SODIUM, PREDNISONE, |
||||
| 80 | 26554537 |
CA |
2 | |
Haemorrhage, Blood iron decreased, Illness, Heavy menstrual bleeding, Blood pressure abnormal, Dizziness, Mobility decreased, Syncope, Unevaluable event, |
||||
UPADACITINIB, |
||||
| 81 | 26554743 |
US |
64 | 2 |
Illness, |
||||
TUCATINIB, |
||||
| 82 | 26554852 |
US |
72 | 1 |
Death, Urine analysis abnormal, Hypoacusis, Nausea, Weight decreased, Decreased appetite, Fatigue, Dysphonia, Hypoaesthesia, Balance disorder, Illness, |
||||
ENFORTUMAB VEDOTIN, GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 83 | 26554867 |
CA |
24 | 2 |
Throat irritation, Illness, Malaise, Nasopharyngitis, Inappropriate schedule of product administration, Off label use, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 84 | 26554956 |
US |
46 | 1 |
Illness, |
||||
PANITUMUMAB, PANITUMUMAB, |
||||
| 85 | 26555116 |
26 | ||
Illness, |
||||
BIMEKIZUMAB, |
||||
| 86 | 26555153 |
US |
59 | 1 |
Coeliac disease, Injection site mass, Illness, Nausea, Injection site pain, Product dose omission issue, Inflammation, Feeling abnormal, Blood triglycerides abnormal, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 87 | 26555205 |
US |
82 | 1 |
Death, Illness, |
||||
VENETOCLAX, SENNOSIDES, SENNA LAXATIVE, SENNOSIDES 8.6 MG, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MELATONIN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, ERGOCALCIFEROL, MIRTAZAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SERTRALINE HYDROCHLORIDE, TESTOSTERONE, EZETIMIBE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LORATADINE, LORATADINE ORAL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, DECITABINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, PREDNISONE, PIRFENIDONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 88 | 26555267 |
US |
1 | |
Fistula, Illness, |
||||
UPADACITINIB, |
||||
| 89 | 26555283 |
US |
83 | 1 |
Pancreatic carcinoma, Anal incontinence, Illness, Small intestinal obstruction, |
||||
PANCRELIPASE, PANCRELIPASE, |
||||
| 90 | 26565639 |
2 | ||
Product dose omission in error, Infection, Illness, Premature menopause, |
||||
FINGOLIMOD HCL, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE, LEVOTHYROXINE SODIUM, |
||||
| 91 | 26569957 |
75 | 1 | |
Hypotension, Dehydration, Lethargy, Decreased appetite, Flushing, Pyrexia, Eye disorder, Illness, Tachycardia, Sepsis, Sedation, Electrolyte imbalance, |
||||
NIVOLUMAB, |
||||
| 92 | 26549008 |
US |
45 | 2 |
Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 93 | 26549078 |
US |
||
Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 94 | 26549093 |
US |
62 | 2 |
Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 95 | 26549114 |
US |
||
Illness, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 96 | 26549283 |
US |
1 | |
Illness, |
||||
DUPILUMAB, |
||||
| 97 | 26549328 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
| 98 | 26549527 |
IN |
1 | |
Illness, |
||||
OLAPARIB, |
||||
| 99 | 26549773 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
| 100 | 26549945 |
US |
70 | 2 |
Product use issue, Extra dose administered, Laryngitis, Throat irritation, Fibromyalgia, Illness, Vomiting, Memory impairment, |
||||
INSULIN HUMAN, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28